Media coverage about Digirad Corporation (NASDAQ:DRAD) has been trending somewhat positive on Tuesday, Accern Sentiment reports. Accern scores the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Digirad Corporation earned a media sentiment score of 0.22 on Accern’s scale. Accern also gave media stories about the medical equipment provider an impact score of 47.049196595146 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Here are some of the news articles that may have impacted Accern’s analysis:

Digirad Corporation (NASDAQ DRAD) traded up $0.02 during midday trading on Tuesday, reaching $2.53. The company had a trading volume of 74,645 shares, compared to its average volume of 207,077. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.31 and a quick ratio of 0.99. Digirad Corporation has a 1 year low of $1.90 and a 1 year high of $5.68. The stock has a market capitalization of $50.94, a P/E ratio of 8.45 and a beta of 1.85.

Digirad Corporation (NASDAQ:DRAD) last posted its quarterly earnings data on Friday, November 3rd. The medical equipment provider reported $0.07 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.03 by $0.04. Digirad Corporation had a negative net margin of 9.93% and a positive return on equity of 9.33%. The business had revenue of $28.56 million for the quarter, compared to analysts’ expectations of $31.21 million. sell-side analysts predict that Digirad Corporation will post 0.17 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 30th. Shareholders of record on Monday, November 20th will be given a dividend of $0.055 per share. This represents a $0.22 dividend on an annualized basis and a yield of 8.71%. The ex-dividend date is Friday, November 17th. Digirad Corporation’s dividend payout ratio (DPR) is -37.29%.

Several research firms recently weighed in on DRAD. B. Riley reiterated a “buy” rating and set a $6.40 target price on shares of Digirad Corporation in a research report on Saturday, August 5th. TheStreet downgraded Digirad Corporation from a “c” rating to a “d+” rating in a research report on Friday.

TRADEMARK VIOLATION NOTICE: This news story was originally published by Watch List News and is the property of of Watch List News. If you are reading this news story on another domain, it was stolen and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at

About Digirad Corporation

Digirad Corporation provides healthcare solutions. The Company’s segments include Diagnostic Services, Mobile Healthcare, Diagnostic Imaging and Medical Device Sales and Services. Through Diagnostic Services, the Company offers an imaging services program as an alternative to purchasing equipment or outsourcing the procedures to another physician or imaging center.

Insider Buying and Selling by Quarter for Digirad Corporation (NASDAQ:DRAD)

Receive News & Ratings for Digirad Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.